5-フローロウラシルと分岐黄金ナノシェルによる化学光熱併用療法により,Xenograft大腸がんモデルにおける腫瘍の縮小が誘発された
Sarah Eliuth Ochoa-Hugo1, Karla Valdivia-Aviña1, Yanet Karina Gutiérrez-Mercado2
1Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco, Unidad de Biotecnología Médica y Farmacéutica, Laboratorio de Investigación Traslacional de Terapias Contra el Cáncer, Guadalajara 44270, Mexico.
Pharmaceutics
|August 28, 2025
まとめ
この研究では,黄金のナノ粒子を5-フッ素ウラシル (5-FU) と近赤外線で組み合わせることで,マウスの大腸がんを効果的に治療し,腫瘍の成長を完全に抑制し,再発を引き起こすことが示されています. この化学光熱療法が がん治療の新たな見込みです
科学分野:
- 腫瘍学
- ナノテクノロジー
- 生物医学工学
背景:
- 癌の治療は,疾患の異質性や治療抵抗性によって困難に直面しています.
- 金ナノ粒子は 局所的な光子エネルギー駆動型高温治療を 提供します
- 化学療法と高温治療を組み合わせると 有望な治療策となります
研究 の 目的:
- 金ナノシェルと5-フッ素ウラシール (5-FU) を用いて結腸直腸がんの組み合わせた有効性を評価する.
- この化学光熱療法による in vitro および in vivo の効果を評価する.
主な方法:
- 800 nmのプラズモン共鳴ピークを持つ分岐金ナノシェル (BGNS) が合成されました.
- 5FUとBGNSを併用してNIR照射した後の生存性を評価する試験では,SW620- GFPの結腸がん細胞を使用した.
- 4週間の間,毎週腫瘍内5FU + BGNS + NIR療法を受けた,異種移植を施した裸のマウスを対象としたインビオ研究.
主要な成果:
- In vitroでは,併用療法により癌細胞の生存能力が90%以上低下しました.
- In vivoでは,5- FU + BGNS + NIRグループは,完全な回帰を観察した100. 74%の腫瘍成長阻害を示しました.
- 腫瘍部位での局所的な高温は45 ±0. 5°Cに達し,熱画像で確認された.
結論:
- 5FUとBGNS媒介の高温の組み合わせは,大腸がんモデルにおいて有意な抗腫瘍効果を示した.
- ナノテクノロジーと化学療法によるこの統合的アプローチは 治療効果を向上させ,全身の毒性を軽減する可能性がある.
- この発見は,より効果的で標的型のがん治療を開発するナノテクノロジーの可能性を強調しています.
さらに関連する動画
関連する概念動画
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


